Today: 16 April 2026
RELX PLC reiterates 2026 growth outlook as AI fears keep pressure on shares
6 March 2026
2 mins read

RELX PLC reiterates 2026 growth outlook as AI fears keep pressure on shares

London, March 6, 2026, 09:00 GMT

RELX PLC stuck to its 2026 growth targets in a March investor deck published Thursday, pointing to wider adoption of artificial intelligence in its product lineup as a driver for both customer value and profits. The latest update, posted after a tough stretch for legal and data names, keeps the FTSE 100 information company pressing its advantage.

The question hanging over RELX right now: will generative AI shore up the company’s businesses, or undercut them? The past month has seen investors wrestling with that. Back in early February, Reuters highlighted how Anthropic’s legal AI tools helped spark a wave of selling in RELX, along with Thomson Reuters and Wolters Kluwer. Yet Thursday saw RELX claw back 2.74%, ending the session at 2,623 pence. The FTSE 100 dropped 1.45%.

The slide deck stuck to RELX’s usual script, forecasting “another year of strong underlying growth” for both revenue and adjusted operating profit. Here, “underlying” backs out currency moves and select portfolio shifts. The deck confirmed 2025 revenue guidance at 9.59 billion pounds, with adjusted operating profit pinned at 3.342 billion pounds, and called for 10% constant-currency growth in adjusted earnings per share. Chief Executive Erik Engstrom pointed to AI, saying it’s set to be “a key driver of customer value and growth in our business for many years to come.” Relx

February’s numbers back up management’s favored narrative. Risk, the top division at RELX, delivered 2025 revenue of 3.485 billion pounds, notching 8% underlying growth. Legal climbed 9%, lifted by the likes of Lexis+ AI and Protégé—AI-powered offerings that drove robust renewals and fresh sales across major segments, according to the company.

RELX highlighted new product moves within its faster-growing segments. On March 5, LexisNexis Risk Solutions announced it’s bringing expanded identity verification tools to the Epic Connection Hub used by U.S. hospitals. Next up: adding IDVerse, an AI-driven system built to spot deepfakes, document forgeries, and other types of fraud.

“Striking a balance between user experience and security is critical in an industry that’s still a prime target for cybercrime,” Jonathan Shannon, AVP of healthcare strategy at LexisNexis Risk Solutions, said in the announcement. LexisNexis Risk Solutions

Not everyone’s convinced this rally makes sense. On March 5, Morningstar’s Rob Hales said, “We still view Thomson, RELX, and Wolters stock as undervalued,” and pointed to “heavy pessimism about the sector” already baked into current prices. Morningstar, Inc.

But the risk hasn’t disappeared. Reuters noted last month that Anthropic’s debut erased value from software and professional-services shares, and this week Goldman Sachs executive Mahesh Saireddy flagged that AI-related uncertainty is making lending decisions trickier. For RELX, the fundamental question lingers: can proprietary data and deeply integrated workflows defend pricing power, or will faster-moving, AI-native newcomers take the lead?

RELX hasn’t let up on cash returns as it continues to push its case. In February, the company outlined a 2.25 billion pound buyback for 2026, followed by a proposed final dividend of 48.0 pence per share. The annual meeting is set for April 23.

Thursday’s bounce didn’t close the gap—shares are still trading roughly 37% under their 52-week high. Investors remain unconvinced; RELX needs to show it can pivot the AI story from risk to real, lasting growth.

Stock Market Today

  • Soybeans Rally Midweek on Strong Demand and Export Sales Outlook
    April 16, 2026, 1:45 AM EDT. Soybeans gained 9 to 11 cents on Wednesday, with the national average cash price rising to $11.01 3/4. Soymeal and soy oil futures also increased, reflecting positive market momentum. Traders anticipate USDA's weekly export sales report Thursday, expecting 200,000 to 600,000 metric tons of old crop beans sold, with new crop sales forecast up to 100,000 MT. NOPA reported a record March crush of 226.16 million bushels, though slightly below estimates. Soybean oil stocks declined 1.97% since February but remain 36% higher year-on-year. May and July soybean contracts closed higher, supported by strong demand signals and steady domestic processing.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 16.04.2026

16 April 2026
LIVEMarkets rolling coverageStarted: April 16, 2026, 12:00 AM EDTUpdated: April 16, 2026, 1:54 AM EDT Soybeans Rally Midweek on Strong Demand and Export Sales Outlook April 16, 2026, 1:45 AM EDT. Soybeans gained 9 to 11 cents on Wednesday, with the national average cash price rising to $11.01 3/4. Soymeal and soy oil futures also increased, reflecting positive market momentum. Traders anticipate USDA's weekly export sales report Thursday, expecting 200,000 to 600,000 metric tons of old crop beans sold, with new crop sales forecast up to 100,000 MT. NOPA reported a record March crush of 226.16 million bushels, though slightly
Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Reckitt Benckiser Shares Sink as 2026 Margin Questions Overshadow Q4 Sales Beat
Previous Story

Reckitt Benckiser Shares Sink as 2026 Margin Questions Overshadow Q4 Sales Beat

GSK steps up share buyback as fresh annual report spells out CEO Luke Miels’ 2026 priorities
Next Story

GSK steps up share buyback as fresh annual report spells out CEO Luke Miels’ 2026 priorities

Go toTop